|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:brand
|
gptkb:Prevacid_Solu_Tab
gptkb:Prevacid_24_HR
|
|
gptkbp:category
|
Category B
|
|
gptkbp:class
|
gptkb:railway_station
|
|
gptkbp:clinical_trial
|
GERD treatment studies
Zollinger-Ellison syndrome studies
peptic ulcer studies
|
|
gptkbp:contraindication
|
hypersensitivity to lansoprazole
|
|
gptkbp:dosage_form
|
enteric-coated
delayed-release
|
|
gptkbp:effective_date
|
gptkb:1995
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:formulation
|
gptkb:beer
gptkb:tablet
suspension
|
|
gptkbp:historical_event
|
introduced in 1995
approved for OTC use in 2009
originally prescription only
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Prevacid
|
|
gptkbp:ingredients
|
gptkb:lansoprazole
|
|
gptkbp:interacts_with
|
gptkb:methotrexate
gptkb:clopidogrel
gptkb:digoxin
gptkb:warfarin
|
|
gptkbp:is_available_on
|
over-the-counter
prescription
|
|
gptkbp:is_used_for
|
treating gastroesophageal reflux disease (GERD)
treating peptic ulcers
treating Zollinger-Ellison syndrome
|
|
gptkbp:lifespan
|
1.5 hours
|
|
gptkbp:manager
|
oral
|
|
gptkbp:manufacturer
|
gptkb:Takeda_Pharmaceuticals
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:products
|
gptkb:esomeprazole
gptkb:omeprazole
gptkb:pantoprazole
rabeprazole
dexlansoprazole
|
|
gptkbp:scholarships
|
do not crush or chew
take before meals
report severe side effects
consult doctor if symptoms persist
|
|
gptkbp:side_effect
|
headache
nausea
abdominal pain
diarrhea
constipation
|
|
gptkbp:storage
|
room temperature
away from moisture
away from heat
|
|
gptkbp:bfsParent
|
gptkb:lansoprazole
|
|
gptkbp:bfsLayer
|
5
|